FDA 483 - Hemarus LLC - November 04, 2022

Hemarus Plasma in Lauderhill, FL, a plasma center, was cited for two observations during an FDA inspection. The inspection revealed inadequate privacy for donor screenings due to uncovered and non-acoustically protected booths, and a failure to thoroughly investigate donor adverse reactions. Several adverse event reports were found missing crucial follow-up and review information.